SCHEMBL9447020

SCHEMBL9447020

O=S(=O)(CCCCl)Nc1ccccc1COc1cccc2cccnc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GLO1 Q04760 5/20 0.55
▸ NPC1 O15118 3/20 0.44
▸ RAB9A P51151 3/20 0.44
▸ SLC40A1 Q9NP59 4/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ POLB P06746 1/20 0.44
▸ GLRA3 O75311 1/20 0.44
▸ GLRB P48167 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.42
▸ METAP2 P50579 2/20 0.42
▸ METAP1 P53582 2/20 0.42
▸ G6PD P11413 1/20 0.42
▸ NFKBIA P25963 1/20 0.42
▸ AGTR1 P30556 1/20 0.42
▸ PAX8 Q06710 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ HDAC6 Q9UBN7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9446955 0.90 GLO1 (0.54) GLO1NPC1RAB9ASLC40A1ALDH1A1
SCHEMBL9447171 0.85 GLO1 (0.58) GLO1NPC1RAB9ASLC40A1ALDH1A1
SCHEMBL9446968 0.80 GLO1 (0.48) GLO1NPC1RAB9AALDH1A1POLB
SCHEMBL9447133 0.80 SLC40A1 (0.67) GLO1SLC40A1ALDH1A1POLBGLRA3
SCHEMBL9447002 0.78 GLO1 (0.69) GLO1NPC1RAB9ASLC40A1ALDH1A1
SCHEMBL9446965 0.76 TP53 (0.46) GLO1NPC1RAB9ASLC40A1ALDH1A1
SCHEMBL9447062 0.76 GLO1 (0.57) GLO1SLC40A1ALDH1A1POLBGLRA3
SCHEMBL9447040 0.75 FABP1 (0.46) GLO1NPC1RAB9ASLC40A1POLB
SCHEMBL9446954 0.74 SLC40A1 (0.70) GLO1SLC40A1MEN1KMT2AMETAP2
SCHEMBL6021515 0.72 RAB9A (0.67) NPC1RAB9AALDH1A1POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5202336-A Lipoxygenase inhibitors BAYER AKTIENGESELLSCHAFT (DE) 1993-04-13 — — US disclosed
US-5093340-A Lipoxygenase enzyme inhibitors, antithrombolytic agents BAYER AKTIENGESELLSCHAFT (DE) 1992-03-03 — — US disclosed
US-5070096-A ANTICOAGULANTS, LIPOXYGENASE INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 1991-12-03 — — US disclosed
EP-0261539-A2 Substituted phenyl-sulphon amides BAYER AG (DE) 1988-03-30 — — EP disclosed
Send feedback